SS Innovations International (SSII) Cash & Current Investments (2016 - 2026)
SS Innovations International (SSII) reported Cash & Current Investments of $23.6 million for Q1 2026, up 8.51% on a YoY basis from $21.8 million in Q1 2025, and up 158.21% sequentially from $9.1 million in Q4 2025.
SS Innovations International (SSII) Cash & Current Investments (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Cash & Current Investments data on file, last reported at $23.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 8.51% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $23.6 million (up 8.51% YoY), and the FY2025 full-year result was $9.1 million, up 45.03% from the prior year.
- Cash & Current Investments grew to $23.6 million in Q1 2026, from $9.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $23.6 million in Q1 2026 to a low of $261089.0 in Q2 2022.
- A 5-year average of $7.3 million and a median of $6.3 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments soared 2467.84% in 2023 and plunged 50.2% in 2024, its largest moves.
- Tracing SSII's Cash & Current Investments over 5 years: stood at $274625.0 in 2022, then soared by 2467.84% to $7.1 million in 2023, then dropped by 10.59% to $6.3 million in 2024, then surged by 45.03% to $9.1 million in 2025, then surged by 158.21% to $23.6 million in 2026.
- Business Quant data shows SSII's Cash & Current Investments at $23.6 million in Q1 2026, $9.1 million in Q4 2025, and $11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | 23.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.61 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Sep 30, 2025 | 11.71 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 21.76 Mn |
| Dec 31, 2024 | 6.31 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 813,453.00 |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 7.05 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 466,346.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 274,625.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |
| Jun 30, 2021 | 307,565.00 |